Astellas Pharma Inc.: U.S. FDA Approves Expanded Label for Astellas' IZERVAY (avacincaptad pegol intravitreal solution) for Geographic Atrophy
IZERVAY dosing approved beyond 12 months TOKYO, Feb. 12, 2025 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today ...
Charleston Gazette-Mail15h
Savvy Senior: How to choose and use a home blood pressure monitor
Can you offer any tips on choosing and using a home blood pressure monitor? I just found out I have high blood pressure and my doctor recommended ...
Investing22h
US Dollar Index (DXY)
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...